Case Study

Orchestrating Distribution Of The First Commercial CAR-T Therapy Drug Product From USA To Japan

Source: Marken, a UPS company
T cells GettyImages-956478348

Distributing cell therapies requires a specialized strategy to safeguard sensitive materials and can be further complicated by varying regulations for global shipments. Ensuring the product is delivered on time and within temperature specifications to the hospital is critical and requires meticulous planning across multiple teams.

This case study outlines how Marken successfully orchestrated the distribution of the first commercial CAR-T therapy drug product from the USA to a hospital in Japan. Navigating time- and temperature-sensitive requirements of transporting a CAR-T drug product in a highly controlled region with strict Japanese healthcare regulations requires logistical teams to comply with unique and rigorous client and procedure stipulations specific to the Japanese biopharma market. Learn more about the strategies put in place to ensure product quality and timeline specifications were properly met.

access the Case Study!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online